Evoke Wealth LLC Sells 31,052 Shares of Doximity, Inc. (NASDAQ:DOCS)

Evoke Wealth LLC lowered its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 11.5% in the fourth quarter, Holdings Channel reports. The institutional investor owned 240,034 shares of the company’s stock after selling 31,052 shares during the period. Evoke Wealth LLC’s holdings in Doximity were worth $12,815,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Shaker Investments LLC OH acquired a new stake in Doximity in the 4th quarter worth about $559,000. Penserra Capital Management LLC acquired a new stake in shares of Doximity in the third quarter valued at approximately $2,384,000. Principal Financial Group Inc. boosted its stake in shares of Doximity by 1.5% in the fourth quarter. Principal Financial Group Inc. now owns 293,974 shares of the company’s stock valued at $15,695,000 after buying an additional 4,282 shares during the period. Newbridge Financial Services Group Inc. acquired a new stake in Doximity during the fourth quarter worth approximately $362,000. Finally, Stratos Wealth Partners LTD. bought a new position in Doximity during the 4th quarter worth $203,000. Institutional investors own 87.19% of the company’s stock.

Insider Activity at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the company’s stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the sale, the director now owns 6,360 shares in the company, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 37.40% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on DOCS. Stephens initiated coverage on Doximity in a research report on Friday, December 20th. They set an “equal weight” rating and a $55.00 target price for the company. Canaccord Genuity Group increased their price objective on shares of Doximity from $60.00 to $71.00 and gave the stock a “hold” rating in a research note on Friday, February 7th. KeyCorp dropped their target price on shares of Doximity from $70.00 to $65.00 and set an “overweight” rating for the company in a research report on Wednesday, January 8th. Leerink Partners upgraded shares of Doximity from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $60.00 to $90.00 in a research report on Friday, February 7th. Finally, Leerink Partnrs upgraded shares of Doximity from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Doximity currently has an average rating of “Moderate Buy” and an average target price of $64.22.

Doximity Stock Performance

Shares of NASDAQ DOCS opened at $62.40 on Tuesday. The firm has a 50 day moving average price of $63.77 and a two-hundred day moving average price of $52.90. The stock has a market cap of $11.65 billion, a P/E ratio of 62.40, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $85.21.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.